Identifying disease progression biomarkers in metabolic associated steatotic liver disease (MASLD) through weighted gene co-expression network analysis and machine learning

被引：0
作者：
Weiliang Zhang [1 ]
Weirong Lu [1 ]
Yaqi Jiao [1 ]
Tianhao Li [1 ]
Haining Wang [2 ]
Chunhua Wan [1 ]
机构：
[1] Department of Nutrition and Food Hygiene, School of Public Health, Nantong University, Jiangsu, Nantong
[2] Department of Cardiovascular Medicine, First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang
来源：
Journal of Translational Medicine | / 23卷 / 1期
基金：
中国国家自然科学基金;
关键词：
Bioinformatics; Disease biomarker; Inflammation; Metabolic associated steatotic liver disease; Weighted gene co-expression network analysis;
D O I：
10.1186/s12967-025-06490-7
中图分类号：
学科分类号：
摘要：
Background: Metabolic Associated Steatotic Liver Disease (MASLD), encompassing conditions simple liver steatosis (MAFL) and metabolic associated steatohepatitis (MASH), is the most prevalent chronic liver disease. Currently, the management of MASLD is impeded by the lack of reliable diagnostic biomarkers and effective therapeutic strategies. Methods: We analyzed eight independent clinical MASLD datasets from the GEO database. Differential expression and weighted gene co-expression network analyses (WGCNA) were used to identify 23 genes related to inflammation. Five hub genes were selected using machine learning techniques (SVM-RFE, LASSO, and RandomForest) combined with a literature review. Nomograms were created to predict MASLD incidence, and the diagnostic potential of the hub genes was evaluated through receiver operating characteristic (ROC) curves. Additionally, Protein-Protein Interaction (PPI) networks, functional enrichment, and immune infiltration analyses were performed. Potential transcription factors and therapeutic agents were also explored. Finally, the expression and biological significance of these hub genes were validated using MASLD animal model, histological examination and transcriptomic profiles. Results: We identified five hub genes—UBD/FAT10, STMN2, LYZ, DUSP8, and GPR88—that are potential biomarkers for MASLD. These genes exhibited strong diagnostic potential, either individually or in combination. Conclusion: This study highlights five key biomarkers as promising candidates for understanding MASLD. These findings offer new insights into the disease’s pathophysiology and may contribute to the development of better diagnostic and therapeutic approaches. © The Author(s) 2025.
引用
收藏
相关论文
共 83 条
  • [51] Garcia-Martinez I., Santoro N., Chen Y., Hoque R., Ouyang X., Caprio S., Shlomchik M.J., Coffman R.L., Candia A., Mehal W.Z., Hepatocyte mitochondrial DNA drives nonalcoholic steatohepatitis by activation of TLR9, J Clin Invest, 126, pp. 859-864, (2016)
  • [52] Moreno-Navarrete J.M., Latorre J., Lluch A., Ortega F.J., Comas F., Arnoriaga-Rodriguez M., Ricart W., Fernandez-Real J.M., Lysozyme is a component of the innate immune system linked to obesity associated-chronic low-grade inflammation and altered glucose tolerance, Clin Nutr Edinb Scotl, 40, pp. 1420-1429, (2021)
  • [53] Latorre J., Lluch A., Ortega F.J., Et al., Adipose tissue knockdown of lysozyme reduces local inflammation and improves adipogenesis in high-fat diet-fed mice, Pharmacol Res, 166, (2021)
  • [54] Keshav S., Chung P., Milon G., Gordon S., Lysozyme is an inducible marker of macrophage activation in murine tissues as demonstrated by in situ hybridization, J Exp Med, 174, pp. 1049-1058, (1991)
  • [55] Meirsman A.C., Ben Hamida S., Clarke E., GPR88 in D1R-Type and D2R-Type medium spiny neurons differentially regulates affective and motor behavior, Eneuro 6:ENEURO, pp. 0035-119, (2019)
  • [56] Komatsu H., Novel therapeutic GPCRs for psychiatric disorders, Int J Mol Sci, 16, pp. 14109-14121, (2015)
  • [57] Meirsman A.C., Robe A.A.B.L., GPR88 in A2AR neurons enhances Anxiety-Like behaviors, Eneuro 3:ENEURO, pp. 0202-0216, (2016)
  • [58] Quintana A., Sanz E., Wang W., Et al., Lack of GPR88 enhances medium spiny neuron activity and alters motor- and cue-dependent behaviors, Nat Neurosci, 15, pp. 1547-1555, (2012)
  • [59] Lau J., Herzog H., CART in the regulation of appetite and energy homeostasis, Front Neurosci, 8, (2014)
  • [60] Lau J., Farzi A., Enriquez R.F., Shi Y.-C., Herzog H., GPR88 is a critical regulator of feeding and body composition in mice, Sci Rep, 7, (2017)
123456789